SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-15-000028
Filing Date
2015-02-24
Accepted
2015-02-24 16:22:32
Documents
3
Period of Report
2015-02-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a4q14form8-k.htm 8-K 28063
2 EXHIBIT 99.1 a4q14financialpr.htm EX-99.1 504464
3 GRAPHIC jazzlogo1a01a01a02.jpg GRAPHIC 26766
  Complete submission text file 0001232524-15-000028.txt   570987
Mailing Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4
Business Address 4TH FLOOR, CONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 15643765
SIC: 2834 Pharmaceutical Preparations